-+ 0.00%
-+ 0.00%
-+ 0.00%

Exicure Agrees To Sell Its GPC-100 Program Assets To GPCRT For ~$4.8M In Cash

Benzinga·11/10/2026 20:54:23

Exicure, Inc. (NASDAQ:XCUR) ("Exicure" or the "Company") today announced that on November 4, 2026, the Company and its wholly owned subsidiary, GPCR Therapeutics USA Inc. ("GPCR USA"), entered into an Intellectual Property, Asset and License Assignment Agreement (the "Agreement") with GPCRT Inc. ("GPCRT"), a company organized under the laws of the Republic of Korea, under which GPCRT has agreed to acquire the Company’s GPC-100 (burixafor) program assets for an aggregate cash purchase price of KRW 6.5 billion (approximately US$4.8 million).